JADBio AutoML (SaaS)
JADBio · Operations & Productivity
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 9 captures on record
What the publisher says
As described on Microsoft Marketplace.
JADBio is the first automated machine learning (AutoML) platform specifically designed for biomedical data. It is able to fully automate the production of predictive models and the identification of the predictive biomarkers from cross-sectional data, of the type that frequently occur in life sciences, e.g., (multi)omic, medical image, physiological signal, and RWE data and their combinations.
JADBio automates even the most complex analysis workflows. Its AI intelligently recognizes the structure of the data and automatically determines which algorithms to apply, how to combine them, how to tune their parameters, and how to present and visualize the results. In doing so, it democratizes data science and machine learning to all stakeholders, Bioinformaticians, Doctors, Biologists, Clinicians and Data Scientists.
Show the rest of the publisher’s description (13 more lines)
JADBio is the only such tool that can reliably scale down to very few samples and so it can be applied to small cohorts (e.g., < 50). It is the only one that can scale up to millions of measured quantities enabling the delivery of data insights across different company operations, driving 8-10x productivity gains and 5-7x cost reductions.
JADBio has been used by more than 10,000 academics and organizations around the world, having appeared in more than 50 publications, leading to the creation of 2 data analysis platforms (one for multi-omics data analysis and another in chemoinformatics) and several discoveries that resulted in 3 patents and 2 recently emerging startups. Some of its highlights include models for
- disease type or sub-type diagnosis (e.g. cancer, mental health, diabetes, etc.),
- risk prediction (e.g. COVID-19),
- therapy efficacy in drug discovery or patient stratification (e.g. chemotherapy), and
- survival or adverse event time prognosis (e.g. metastasis, relapse).
What you get using JADBio
- Decision making rooted in data insights by AI/ML. o Uncover trends and actionable insights by leading proprietary tools and expertise
- Faster R&D discoveries o Augment your team's capacity and productivity, by reducing multifold the time and cost of research data analysis.
- Maximize impact by reduced failure rates o Identify valid biomarkers, early in the pipeline by trusted ML
- Real-world and multimodal data capabilities for personalized solutions o Tailor treatments to any type, any size, and any combination of data including molecular, imaging, clinical, and patient-reported/generated data.
- Enhanced agility
o Minimum error, rapid prototyping driving continuous improvement and outputs refinement.
Preview
5 images
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Vendor
External enrichment
Plans and pricing as listed
1 listedSources
Publisher resources
5 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.